Skip to main content
Erschienen in: International Urogynecology Journal 5/2019

01.05.2019 | Original Article

Vitamin E as alternative local treatment in genitourinary syndrome of menopause: a randomized controlled trial

verfasst von: Nahid Golmakani, Aazam Parnan Emamverdikhan, Ahmadreza Zarifian, Sayyed Abolghasem Sajadi Tabassi, Malihe Hassanzadeh

Erschienen in: International Urogynecology Journal | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Genitourinary syndrome of menopause is a major health concern in postmenopausal women. This study was aimed at comparing the effect of a vitamin E vaginal suppository with that of conjugated estrogen vaginal cream on sexual function in postmenopausal women with genitourinary syndrome of menopause.

Methods

This survey was carried out on 52 postmenopausal women aged 40–65 years who had been referred to gynecology clinics in Mashhad city, during 2013–2014. Keeping β = 0.1, the power was calculated to be 90%. The patients were randomly divided into two groups: vitamin E vaginal suppository and conjugated estrogen vaginal cream. Participants used the medications for 12 weeks. They were visited at the 4th, 8th, and 12th weeks. Validated Abbreviated Sexual Function Questionnaire (ASFQ), as the primary outcome measure, and a demographic information questionnaire, were used to collect data at each visit. Data were analyzed using SPSS and p < 0.05 was considered statistically significant.

Results

Mean overall scores of the ASFQ were increased significantly in both groups during the course of the study, compared with baseline (p < 0.001). However, the mean ASFQ scores of the two treatments did not differ significantly.

Conclusion

Improved scores of ASFQ after the 12th week showed that the treatment was successful in both groups. Therefore, a vitamin E vaginal suppository may be an alternative to vaginal estrogen in relieving the symptoms of vaginal atrophy in postmenopausal women, especially those not able to use hormone therapy or have low compliance.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Thompson WK, Charo L, Vahia IV, Depp C, Allison M, Jeste DV. Association between higher levels of sexual function, activity, and satisfaction and self-rated successful aging in older postmenopausal women. J Am Geriatr Soc. 2011;59(8):1503–8.CrossRefPubMedPubMedCentral Thompson WK, Charo L, Vahia IV, Depp C, Allison M, Jeste DV. Association between higher levels of sexual function, activity, and satisfaction and self-rated successful aging in older postmenopausal women. J Am Geriatr Soc. 2011;59(8):1503–8.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Palacios S, Tobar A, Menendez C. Sexuality in the climacteric years. Maturitas. 2002;43:69–77.CrossRef Palacios S, Tobar A, Menendez C. Sexuality in the climacteric years. Maturitas. 2002;43:69–77.CrossRef
4.
Zurück zum Zitat Goldstein I, Dicks B, Kim NN, Hartzell R. Multidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal women. Sex Med. 2013;1(2):44–53.CrossRefPubMedPubMedCentral Goldstein I, Dicks B, Kim NN, Hartzell R. Multidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal women. Sex Med. 2013;1(2):44–53.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Nappi R, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014;17(1):3–9.CrossRefPubMed Nappi R, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014;17(1):3–9.CrossRefPubMed
6.
Zurück zum Zitat Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J Sex Med. 2005;2(s3):154–65.CrossRefPubMed Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J Sex Med. 2005;2(s3):154–65.CrossRefPubMed
7.
Zurück zum Zitat Sturdee D, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13(6):509–22.CrossRefPubMed Sturdee D, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13(6):509–22.CrossRefPubMed
8.
Zurück zum Zitat Galantino ML, Canella C, House L, Kondos L, Suydam A, Doran J, et al. Complementary and alternative therapies for women transitioning through menopause. J Womens Health Phys Therap. 2006;30(3):18–26.CrossRef Galantino ML, Canella C, House L, Kondos L, Suydam A, Doran J, et al. Complementary and alternative therapies for women transitioning through menopause. J Womens Health Phys Therap. 2006;30(3):18–26.CrossRef
11.
Zurück zum Zitat Baziad A. Diagnosis and management of vaginal dryness in menopause. Majalah Obstet Ginekol Indones. 2017;24(2):70–3.CrossRef Baziad A. Diagnosis and management of vaginal dryness in menopause. Majalah Obstet Ginekol Indones. 2017;24(2):70–3.CrossRef
12.
Zurück zum Zitat Schmidt P. The 2012 hormone therapy position statement of the North American Menopause Society. Menopause. 2012;19(3):257.CrossRef Schmidt P. The 2012 hormone therapy position statement of the North American Menopause Society. Menopause. 2012;19(3):257.CrossRef
13.
Zurück zum Zitat Cardini F, Lesi G, Lombardo F, Sluijs C. The use of complementary and alternative medicine by women experiencing menopausal symptoms in Bologna. BMC Womens Health. 2010;10(1):1.CrossRef Cardini F, Lesi G, Lombardo F, Sluijs C. The use of complementary and alternative medicine by women experiencing menopausal symptoms in Bologna. BMC Womens Health. 2010;10(1):1.CrossRef
14.
Zurück zum Zitat Ziagham S, Abbaspour Z, Abbaspour MR. The comparison between the effects of hyaluronic acid vaginal suppository and vitamin E on the treatment of atrophic vaginitis in menopausal women. J Arak Uni Med Sci. 2012;15(6):57–64. Ziagham S, Abbaspour Z, Abbaspour MR. The comparison between the effects of hyaluronic acid vaginal suppository and vitamin E on the treatment of atrophic vaginitis in menopausal women. J Arak Uni Med Sci. 2012;15(6):57–64.
15.
Zurück zum Zitat Borrelli F, Ernst E. Alternative and complementary therapies for the menopause. Maturitas. 2010;66(4):333–43.CrossRefPubMed Borrelli F, Ernst E. Alternative and complementary therapies for the menopause. Maturitas. 2010;66(4):333–43.CrossRefPubMed
19.
Zurück zum Zitat Shobeiri F, Nazari M. Age at menopause and its main predictors among Iranian women. Int J Fertil Steril. 2014;8(3):267–72.PubMedPubMedCentral Shobeiri F, Nazari M. Age at menopause and its main predictors among Iranian women. Int J Fertil Steril. 2014;8(3):267–72.PubMedPubMedCentral
21.
Zurück zum Zitat Guay A, Munarriz R, Jacobson J, Talakoub L, Traish A, Quirk F, et al. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20–49 years with no complaints of sexual dysfunction. Int J Impot Res. 2004;16(2):112–20.CrossRefPubMed Guay A, Munarriz R, Jacobson J, Talakoub L, Traish A, Quirk F, et al. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20–49 years with no complaints of sexual dysfunction. Int J Impot Res. 2004;16(2):112–20.CrossRefPubMed
22.
Zurück zum Zitat Nappi RE, Polatti F. Continuing medical education: the use of estrogen therapy in women's sexual functioning (CME). J Sex Med. 2009;6(3):603–16.CrossRefPubMed Nappi RE, Polatti F. Continuing medical education: the use of estrogen therapy in women's sexual functioning (CME). J Sex Med. 2009;6(3):603–16.CrossRefPubMed
23.
24.
Zurück zum Zitat Ziaei S, Kazemnejad A, Zareai M. The effect of vitamin E on hot flashes in menopausal women. Gynecol Obstet Investig. 2007;64(4):204–7.CrossRef Ziaei S, Kazemnejad A, Zareai M. The effect of vitamin E on hot flashes in menopausal women. Gynecol Obstet Investig. 2007;64(4):204–7.CrossRef
25.
Zurück zum Zitat Kashanian M, Lakeh MM, Ghasemi A, Noori S. Evaluation of the effect of vitamin E on pelvic pain reduction in women suffering from primary dysmenorrhea. J Reprod Med. 2012;58(1–2):34–8. Kashanian M, Lakeh MM, Ghasemi A, Noori S. Evaluation of the effect of vitamin E on pelvic pain reduction in women suffering from primary dysmenorrhea. J Reprod Med. 2012;58(1–2):34–8.
26.
Zurück zum Zitat Abedinzade M, Safari A. Comparison of acupressure effect on Sanyinjiao point with that of vitamin E on primary dysmenorrhea. Armaghane Danesh. 2009;14(3):35–43. Abedinzade M, Safari A. Comparison of acupressure effect on Sanyinjiao point with that of vitamin E on primary dysmenorrhea. Armaghane Danesh. 2009;14(3):35–43.
27.
Zurück zum Zitat Herold E, Mottin J, Sabry Z. Effect of vitamin E on human sexual functioning. Arch Sex Behav. 1979;8(5):397–403.CrossRefPubMed Herold E, Mottin J, Sabry Z. Effect of vitamin E on human sexual functioning. Arch Sex Behav. 1979;8(5):397–403.CrossRefPubMed
28.
Zurück zum Zitat Hobson R. Vitamin E and wound healing: an evidence-based review. Int Wound J. 2014;13(3):331–5.CrossRefPubMed Hobson R. Vitamin E and wound healing: an evidence-based review. Int Wound J. 2014;13(3):331–5.CrossRefPubMed
29.
Zurück zum Zitat Elliott S, Lam W, Derzko C. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol. 2007;14(Suppl 1):S20–40.CrossRefPubMedPubMedCentral Elliott S, Lam W, Derzko C. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol. 2007;14(Suppl 1):S20–40.CrossRefPubMedPubMedCentral
30.
Metadaten
Titel
Vitamin E as alternative local treatment in genitourinary syndrome of menopause: a randomized controlled trial
verfasst von
Nahid Golmakani
Aazam Parnan Emamverdikhan
Ahmadreza Zarifian
Sayyed Abolghasem Sajadi Tabassi
Malihe Hassanzadeh
Publikationsdatum
01.05.2019
Verlag
Springer International Publishing
Erschienen in
International Urogynecology Journal / Ausgabe 5/2019
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-018-3698-z

Weitere Artikel der Ausgabe 5/2019

International Urogynecology Journal 5/2019 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Menopausale Hormontherapie für Frauen über 65?

07.05.2024 Klimakterium und Menopause Nachrichten

In den USA erhalten nicht wenige Frauen auch noch im Alter über 65 eine menopausale Hormontherapie. Welche positiven und negativen gesundheitlichen Konsequenzen daraus möglicherweise resultieren, wurde anhand von Versicherungsdaten analysiert.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.